Skip to content

Pilot Study on the Tolerability of Dietary Dried Plum

Pilot Study on the Tolerability of Dietary Dried Plum

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01035372
Enrollment
6
Registered
2009-12-18
Start date
2009-12-31
Completion date
2010-09-30
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly, Healthy

Keywords

healthy older people

Brief summary

Dried plums (Prunus domestica L.) have traditionally been recognized for their health benefits related to conditions such as constipation, irregular menstrual cycles and mouth sores. This dried fruit provides high levels of fiber, vitamins and minerals. Dried plum has also been shown in animal studies to have beneficial effects on bone and can prevent the loss of bone caused by low hormone levels such as occurs after surgical removal of the ovaries. We also have shown that dried plum can prevent the loss of bone associated with aging in mice. Very few therapies for osteoporosis actually reverse bone loss and improve bone strength. The potential therapeutic value of dried plum in men and women with hormone deficiency or age-related osteoporosis is clear.

Interventions

DIETARY_SUPPLEMENTdried plum powder

subjects will have 25% of their diet substituted by dried plum powder

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 50 yrs and 75 yrs * Nonsmokers * Normal renal and hepatic function

Exclusion criteria

* Subjects who must follow a specific diet * Subjects on any daily medications that affect bone health * Subjects too heavy for the DEXA machine (weight limit 300 lbs) * Subjects whose BMD by DEXA indicates osteoporosis * Subjects unwilling to follow the diet specified * Pregnant women * Subjects who are unable to understand the consent form.

Design outcomes

Primary

MeasureTime frame
urinary calcium excretionone month

Secondary

MeasureTime frame
ability to tolerate the dietone month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026